BSE Live
Dec 31, 16:00Prev. Close
62.36
Open Price
62.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
59.25 (68011)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 1.57 | 1.57 | 10.17 | 8.99 | 8.99 | |
| Total Share Capital | 1.57 | 1.57 | 10.17 | 8.99 | 8.99 | |
| Reserves and Surplus | 12.39 | 12.26 | -10.60 | -7.51 | -8.47 | |
| Total Reserves and Surplus | 12.39 | 12.26 | -10.60 | -7.51 | -8.47 | |
| Total Shareholders Funds | 13.95 | 13.82 | -0.43 | 1.47 | 0.52 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1.20 | 0.31 | 10.12 | 10.49 | 0.99 | |
| Deferred Tax Liabilities [Net] | 2.29 | 2.16 | 2.09 | 2.09 | 0.99 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 3.48 | 2.47 | 12.21 | 12.58 | 1.98 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 4.24 | |
| Trade Payables | 0.71 | 1.28 | 1.47 | 1.20 | 4.04 | |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Short Term Provisions | 0.17 | 0.17 | 0.29 | 0.70 | 0.52 | |
| Total Current Liabilities | 0.87 | 1.45 | 1.76 | 1.90 | 8.80 | |
| Total Capital And Liabilities | 18.31 | 17.74 | 13.54 | 15.96 | 11.30 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 9.72 | 9.58 | 10.13 | 2.34 | 2.28 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 1.68 | 1.66 | 0.00 | 0.05 | 0.05 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 11.40 | 11.24 | 10.13 | 2.39 | 2.32 | |
| Non-Current Investments | 0.03 | 0.05 | 0.01 | 0.01 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 11.44 | 11.29 | 10.14 | 2.40 | 2.32 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 1.35 | 1.14 | 1.23 | 0.92 | 0.64 | |
| Trade Receivables | 0.50 | 0.46 | 1.29 | 4.20 | 5.31 | |
| Cash And Cash Equivalents | 0.59 | 0.51 | 0.08 | 0.04 | 0.24 | |
| Short Term Loans And Advances | 4.38 | 4.33 | 0.80 | 8.40 | 2.79 | |
| OtherCurrentAssets | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 6.87 | 6.45 | 3.40 | 13.56 | 8.98 | |
| Total Assets | 18.31 | 17.74 | 13.54 | 15.96 | 11.30 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.03 | 0.05 | 0.01 | 0.01 | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y